Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age55+
SponsorUniversity of Texas Southwestern Medical Center

About this trial

This study will probe if the biological changes in amnestic mild cognitive impairment (aMCI) are related to a history of mild traumatic brain injury (mTBI) using high definition transcranial direct current stimulation (HD-tDCS) and blood-derived biomarker tools. Participants who Do as well as those who Do Not have a history of mTBI will be enrolled in the study.

Eligibility criteria

Qualifiers

Active diagnosis of amnestic mild cognitive impairment

Presence of an mTBI history for the mTBI+ group; absence of an mTBI history for a control sample

Female and male subjects

All races/ethnicities

Disqualifiers

Mild traumatic brain injury within past year

Lifetime history of moderate or severe brain injury

Lifetime major neurologic syndromes (e.g., stroke, epilepsy, brain tumor)

Lifetime major cardiovascular conditions (e.g., heart attack, heart failure)

Trial design

Treatments tested in this trial

  • High Definition Transcranial Direct Current Stimulation

Treatment groups

75 Participants
are divided into 3 treatment groups